LOW-DOSE CYTARABINE - COMPLETE REMISSION IN A PATIENT WITH ACUTE MYELOID-LEUKEMIA IN RELAPSE SUGGESTING A DIFFERENTIATION EFFECT

被引：0
|
作者：
ABBADESSA, A [1 ]
BRUZZESE, L [1 ]
ARCIDIACONE, G [1 ]
机构：
[1] FAC MED & CHIRURG NAPOLI 1,MED CLIN,NAPOLI,ITALY
来源：
ACTA HAEMATOLOGICA | 1987年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：211 / 212
页数：2
相关论文
共 50 条
  • [31] Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation
    R Trenschel
    M Bernier
    P Stryckmans
    A Verhest
    R Badjou
    P Crombez
    D Bron
    Bone Marrow Transplantation, 1997, 19 : 381 - 383
  • [32] IDARUBICIN, HIGH-DOSE CYTARABINE AND ETOPOSIDE FOR REMISSION INDUCTION IN THERAPY-RELATED ACUTE MYELOID-LEUKEMIA
    PHILPOTT, N
    MEHTA, J
    TRELEAVEN, J
    POWLES, R
    LEUKEMIA & LYMPHOMA, 1994, 15 (1-2) : 127 - 130
  • [33] Complete remission following donor PBSC after low-dose cytarabine chemotherapy for early relapse of acute myelogenous leukemia after allogeneic stem cell transplantation
    Trenschel, R
    Bernier, M
    Stryckmans, P
    Verhest, A
    Badjou, R
    Crombez, P
    Bron, D
    BONE MARROW TRANSPLANTATION, 1997, 19 (04) : 381 - 383
  • [34] TREATMENT OF ACUTE MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME BY LOW-DOSE ARABINOSYL CYTOSINE
    BACCARANI, M
    FASOLA, G
    FANIN, R
    MORASSI, P
    FLOREAN, M
    POZZATO, G
    CAVAZZINI, G
    ZACCARIA, A
    GUARINI, L
    LODI, L
    COLLE, R
    MAGRIS, D
    LIPIZER, A
    DAGNOLO, B
    PRIA, MD
    CAZZOLA, R
    CHIZZOLA, A
    HAEMATOLOGICA, 1985, 70 (02) : 160 - 165
  • [35] Autophagy is an important event for low-dose cytarabine treatment in acute myeloid leukemia cells
    Chen, Liyun
    Guo, Pei
    Zhang, Yunxiang
    Li, Xiaoyang
    Jia, Peimin
    Tong, Jianhua
    Li, Junmin
    LEUKEMIA RESEARCH, 2017, 60 : 44 - 52
  • [36] THE SELECTIVE USE OF AMSA FOLLOWING HIGH-DOSE CYTARABINE IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA IN RELAPSE - A LEUKEMIA INTERGROUP STUDY
    LARSON, RA
    DAY, RS
    AZARNIA, N
    BENNETT, JM
    BROWMAN, G
    GOLDBERG, J
    GOTTLIEB, A
    GRUNWALD, H
    MILLER, K
    RAZA, A
    VOGLER, R
    WINTON, E
    PREISLER, HD
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 82 (02) : 337 - 346
  • [37] REMISSION WITH MORPHOLOGICAL MYELODYSPLASIA IN DENOVO ACUTE MYELOID-LEUKEMIA - IMPLICATIONS FOR EARLY RELAPSE
    NAGAI, K
    MATSUO, T
    ATOGAMI, S
    MORIUCHI, Y
    YOSHIDA, Y
    KURIYAMA, K
    TOMONAGA, M
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (01) : 33 - 39
  • [38] Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemia
    Sekeres, Mikkael A.
    Lancet, Jeffrey E.
    Wood, Brent L.
    Grove, Laurie E.
    Sandalic, Larissa
    Sievers, Eric L.
    Jurcic, Joseph G.
    HAEMATOLOGICA, 2013, 98 (01) : 119 - 128
  • [39] LOW-DOSE ARA-C CAN CAUSE COMPLETE REMISSION OF ACUTE NONLYMPHOCYTIC LEUKEMIA - DIFFERENTIATION INDUCTION
    YE, JS
    FENG, GH
    LIANG, GR
    TAO, MX
    LEUKEMIA RESEARCH, 1986, 10 (10) : 1221 - 1224
  • [40] MITOZANTRONE AND HIGH-DOSE CYTARABINE IN REFRACTORY ADULT ACUTE MYELOID-LEUKEMIA
    HIDDEMANN, W
    KREUTZMANN, H
    LUDWIG, WD
    AUL, HC
    DONHUIJSENANT, R
    LENGFELDER, E
    BUCHNER, T
    LANCET, 1985, 2 (8453): : 508 - 509
12345